Glenmark Pharmaceuticals Limited — Others, 01-08-2025: Shareholders meeting

Glenmark Pharmaceuticals' shareholders have approved the appointment of Mr. Anurag Mantri as the Whole-time Director, Executive Director, and Global Chief Financial Officer via postal ballot. Out of 28.22 Cr total shares, 23.38 Cr shares were voted, representing 82.86% of the company's paid-up equity. The resolution passed overwhelmingly, with 22.74 Cr votes (97.25%) in favor and 0.64 Cr votes (2.75%) against. This solidifies a key leadership role, impacting the company's financial strategy and operational oversight.